U.S. Markets closed

electroCore, Inc. (ECOR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.4800-0.0100 (-0.67%)
At close: 1:00PM EST

electroCore, Inc.

150 Allen Road
Suite 201
Basking Ridge, NJ 07920
United States
973 290 0097
http://www.electrocore.com

Sector(s)Healthcare
IndustryMedical Instruments & Supplies
Full Time Employees51

Key Executives

NameTitlePayExercisedYear Born
Mr. Daniel S. GoldbergerCEO & Director187.5kN/A1959
Mr. Joseph P. ErricoCo-Founder, Principal Investor & Director776.28kN/A1969
Mr. Brian M. PosnerCFO & Corp. Sec.380.54kN/A1962
Dr. Peter S. StaatsChief Medical Officer238.41kN/A1964
Mr. Michael RomaniwExec. VP of Systems & OperationsN/AN/A1957
Mr. Eric J. LieblerSr. VP of NeurologyN/AN/A1964
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of patient administered non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld delivery system for multi-year use prescribed on a monthly basis. The company was founded in 2005 and is headquartered in Basking Ridge, New Jersey.

Corporate Governance

electroCore, Inc.’s ISS Governance QualityScore as of November 1, 2019 is 9. The pillar scores are Audit: 5; Board: 9; Shareholder Rights: 8; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.